Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UC-MSC injection
- Development stage
- Preclinical
- Lead developer
- Shandong Qilu Stem Cell Engineering
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Injection
01
Overview
UC-MSC injection is an umbilical cord-derived mesenchymal stem cell therapy developed by Shandong Province Qilu Stem Cells Engineering. The product is designed to treat moderate-to-severe persistent allergic rhinitis by leveraging the innate immunomodulatory properties of mesenchymal stem cells. These cells are thought to migrate to sites of inflammation and release paracrine factors that suppress overactive Th2 immune responses, modulate T-cell activity, and reduce the production of pro-inflammatory cytokines, thereby alleviating the symptoms of allergic inflammation. It is currently being evaluated in clinical research projects registered under the Chinese stem cell clinical research filing system.
- Other names
- Umbilical Cord Mesenchymal Stem CellsUC-MSC
Beyond the preview
Go deeper on UC-MSC injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UC-MSC injection.